Serum Institute to launch a new vaccine every year, says Poonawala
The group is also investing Rs. 1,500-2,000 crore, half of which has already been spent for clinical trials for new vaccines in the pipeline as well as in a new biotech SEZ in Pune that will make products for Europe amongst other geographies, Poonawala told BusinessLine. The new facility is scheduled to go on stream in 2018.
“Though Serum exports to over 140 countries, we have not been able to enter Europe because the quality and regulations standards are such that you really have to up your investment and game,” he explained.
The new facility, which is being funded through internal accruals, will also enable Serum to raise its current capacity of 1.2 billion doses by another 500 million doses over the next five years and create space for making newer vaccines.